These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24612251)

  • 21. The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Manolakopoulos S; Margariti A; Papageorgiou MV; Kranidioti H; Katoglou A; Kontos G; Adamidi S; Kafiri G; Deutsch M; Pectasides D
    J Viral Hepat; 2014 Jul; 21(7):517-24. PubMed ID: 24750382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.
    Rinaldi L; Ascione A; Messina V; Rosato V; Valente G; Sangiovanni V; Zampino R; Marrone A; Fontanella L; de Rosa N; Orabona P; Buonomo C; Chirianni A; Adinolfi LE; Piai G
    Infection; 2018 Apr; 46(2):231-238. PubMed ID: 29335905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers.
    Mena Á; Pedreira JD; Castro Á; López S; Vázquez P; Poveda E
    J Gastroenterol Hepatol; 2014 Jan; 29(1):173-8. PubMed ID: 24219115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.
    Seto WK; Hui RWH; Mak LY; Fung J; Cheung KS; Liu KSH; Wong DK; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):575-583.e2. PubMed ID: 28970146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study.
    Wang XD; Pan CW; Zhou GY; Gao F; Wang FL; Fu RQ; Xiao EH; Li P; Zhang H; Zheng MH
    J Viral Hepat; 2022 Mar; 29(3):196-204. PubMed ID: 34902216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agents.
    Kim JK; Ma DW; Lee KS; Paik YH
    J Korean Med Sci; 2014 Apr; 29(4):570-5. PubMed ID: 24753706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
    Dong XQ; Wu Z; Li J; Wang GQ; Zhao H;
    J Gastroenterol Hepatol; 2019 Apr; 34(4):755-763. PubMed ID: 30290019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B.
    Wong GL; Wong VW; Choi PC; Chan AW; Chan HL
    Aliment Pharmacol Ther; 2010 May; 31(10):1095-103. PubMed ID: 20180785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
    J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
    Kim SU; Lee JH; Kim DY; Ahn SH; Jung KS; Choi EH; Park YN; Han KH; Chon CY; Park JY
    PLoS One; 2012; 7(5):e36676. PubMed ID: 22574212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue.
    Jang W; Yu SI; Sinn DH; Park SH; Park H; Park JY; Jeon TJ; Oh TH; Shin WC; Choi WC
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):195-200. PubMed ID: 24231289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
    Jia J; Hou J; Ding H; Chen G; Xie Q; Wang Y; Zeng M; Zhao J; Wang T; Hu X; Schuppan D
    J Gastroenterol Hepatol; 2015 Apr; 30(4):756-62. PubMed ID: 25353058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central Obesity and Advanced Liver Stiffness in Hepatitis B: Result from Golestan Hepatitis B Cohort Study.
    Besharat S; Poustchi H; Mohamadkhani A; Roshandel G; Freedman ND; Merat S; Malekzadeh R
    Arch Iran Med; 2015 Sep; 18(9):562-6. PubMed ID: 26317595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.
    Kim BK; Han KH; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Kim DY
    Liver Int; 2010 Aug; 30(7):1073-81. PubMed ID: 20492510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
    Mak LY; Wong DK; Cheung KS; Hui RW; Liu F; Fung J; Seto WK; Yuen MF
    Dig Dis Sci; 2022 Nov; 67(11):5127-5136. PubMed ID: 35258755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B.
    Miller M; Heron T; Dillon J
    Aliment Pharmacol Ther; 2014 May; 39(10):1236. PubMed ID: 24735137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.